Samuel Isaly’s OrbiMed Advisors manages around $5 Billion in healthcare related equities and venture capital. Eaton Vance Worldwide Health Sciences Fund managed to beat the S&P 500 index by more than 5 percentage points per year since Isaly took...
Anthera Pharmaceuticals, Inc. (NasdaqANTH), today announced financial results and business highlights for the third quarter ended September 30, 2010.
Total operating expenses for the third quarter ended September...(read more
Shares of Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) are skyrocketing today, up more than 30% on strong volume.
There is no news out on the stock that would cause the stock to have such a sharp runup, but it is being actively...(read more